Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 7912764.
- Also identified by PMC identifier 2962586.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We have previously postulated that donor cell chimerism in organ transplantation is needed to attain a tolerant state. Here we show that donor cell chimerism can be augmented in organ recipients if they are infused perioperatively with 3 x 10(8) per kg of unmodified donor bone marrow cells and are kept on a conventional immunosuppressive regimen of tacrolimus (FK506) and prednisolone. 36 patients took part, of whom the first 18 patients have good transplanted kidney (n = 10), liver (n = 7), and heart (n = 7) function when followed up between 4 and 16 months. All patients are well. We found persistent multilineage leucocyte chimerism in blood of 17 recipients by flow cytometry and PCR techniques to detect donor alleles or Y chromosomes in female recipients of male organs. The use of the 5-antigben HLA matched same sex donor precluded detection of chimerism in one patient.
Medical subject headings
- Bone Marrow Transplantation
- Graft Survival
- Islets of Langerhans Transplantation
- Organ Transplantation
- Transplantation Chimera
- Transplantation Immunology